DanCann Pharma Feed

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2023-01-04 09:00:00 DanCann Pharma A/S has appointed Peter Søndergaard as new fulltime CFO +7,50% | 0,09 MDKK

2022-12-21 09:00:00 DanCann Pharma A/S strengthening the organization with new Head of Regulatory Affairs -1,19% | 0,06 MDKK

2022-12-14 09:00:00 DanCann Pharma A/S: A strengthened market position after an impressive H2-2022 +3,23% | 0,14 MDKK

2022-12-13 09:00:00 DanCann Pharma A/S: CannGros ApS' new facilities in Ansager have been approved by the Danish Medicines Agency for import, repackaging and distribution +0,81% | 0,14 MDKK

2022-12-12 09:00:00 DanCann Pharma A/S: The US will enable more research into medical cannabis -4,65% | 0,45 MDKK

2022-12-05 08:00:00 DanCann Pharma A/S' shares commence trading on the OTCQB venture market in the United States -21,46% | 1,79 MDKK

2022-12-02 08:00:00 DanCann Pharma A/S receives EU-GMP certification for its manufacturing facility Biotech Pharm1 +4,61% | 0,30 MDKK

2022-11-30 15:50:00 DanCann Pharma A/S announces last day for trading in BTU and the first day of trading in the warrants of series TO 2 +5,33% | 0,09 MDKK

2022-11-17 17:30:00 DanCann Pharma A/S announces outcome of the Rights Issue -9,71% | 0,13 MDKK

2022-11-10 12:00:00 DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions +5,23% | 0,09 MDKK

2022-11-09 08:00:00 Last day of subscription of units in DanCann Pharma A/S ongoing rights issue and guidance on how to subscribe +6,27% | 0,44 MDKK

2022-11-08 10:00:00 DanCann Pharma A/S with inspection by the Danish Medicine Agency during Q4-2022: expects to get EU-GMP approval before end-2022 -1,82% | 0,83 MDKK

2022-11-07 15:25:00 DanCann Pharma A/S' Board of Directors and Management have subscribed for units in the ongoing Rights Issue 0,00% | 0,31 MDKK

2022-11-04 11:15:00 DanCann Pharma A/S publishes a supplement to the prospectus for the rights issue -9,38% | 0,23 MDKK

2022-11-04 08:00:00 DanCann Pharma A/S publishes Q3-2022 report -9,38% | 0,23 MDKK

2022-11-03 09:20:00 DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million +9,58% | 0,41 MDKK

2022-11-02 08:59:12 BioStock Investor Pitch: DanCann Pharma +0,28% | 0,08 MDKK

2022-11-01 09:00:00 DanCann Pharma A/S targeting annual revenue of approx. DKK 60-100 million - and with several new partner agreements in the pipeline +2,57% | 0,20 MDKK

2022-10-31 08:45:00 DanCann Pharma A/S: The subscription period in DanCann Pharma's Rights Issue begins today -10,94% | 0,32 MDKK

2022-10-27 13:00:00 DanCann Pharma A/S: Exciting developments in Germany regarding legalization of cannabis -0,63% | 0,22 MDKK

2022-10-24 17:00:00 DanCann Pharma A/S brings forward the release of the quarterly report for Q3 2022 -0,55% | 0,05 MDKK

2022-10-21 11:30:00 Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus -2,80% | 0,06 MDKK

2022-10-11 09:00:00 DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide 0,00% | 0,02 MDKK

2022-09-22 13:00:00 DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors +6,12% | 0,05 MDKK

2022-09-20 15:10:51 DanCann Pharma A/S: Minutes of annual general meeting +2,44% | 0,07 MDKK

2022-09-12 10:00:00 DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project -13,39% | 0,32 MDKK

2022-09-05 13:55:00 DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue +0,62% | 0,36 MDKK

2022-09-05 08:00:00 DanCann Pharma A/S: Notice of extraordinary general meeting +0,62% | 0,36 MDKK

2022-08-31 08:30:00 DanCann Pharma A/S intends to resolve on a partially (77 percent) guaranteed rights issue of approximately DKK 28.5 million -58,33% | 3,59 MDKK

2022-08-31 08:00:00 DanCann Pharma A/S publishes Q2-2022 report -58,33% | 3,59 MDKK

2022-08-29 15:50:00 DanCann Pharma A/S signs supply agreement with WEECO Pharma GmbH worth DKK 40 million +16,28% | 0,82 MDKK

2022-08-24 09:00:00 DanCann Pharma A/S: According to a recent opinion poll a majority of Danes are positive towards legalization of cannabis 0,00% | 0,07 MDKK

2022-08-19 19:00:00 DanCann Pharma A/S postpones quarterly report for Q2 2022 0,00% | 0,06 MDKK

2022-08-19 09:00:00 DanCann Pharma A/S: Standardized medicinal cannabis products are essential for the medical profession - and ultimately for the patients 0,00% | 0,10 MDKK

2022-08-16 09:00:00 DanCann Pharma A/S appoints Charlotte Hagedorn Jørgensen as new Head of Quality Assurance -0,89% | 0,15 MDKK

2022-08-11 09:00:00 DanCann Pharma A/S: CEO Jeppe Krog Rasmussen appointed to the board of The Danish Association of Listed Growth Companies -3,80% | 0,12 MDKK

2022-08-05 10:00:00 DanCann Pharma A/S: The acquisition of CannGros ApS shows a prominent EBITDA of DKK 1.6 million for the annual 2021-report +0,39% | 0,18 MDKK

2022-07-15 18:20:00 DanCann Pharma A/S has prolonged its loan facility of SEK 13.7 million +0,40% | 0,05 MDKK

2022-05-18 17:00:00 DanCann Pharma A/S publishes Q1-2022 report: Facing commercialization stage +14,15% | 0,35 MDKK

2022-05-16 11:00:00 DanCann Pharma A/S: Establishing a new benchmark in the industry as impressive test results show extreme product purity without the use of radiation +8,00% | 0,12 MDKK

2022-05-12 09:00:00 DanCann Pharma A/S signs Letter of Intent with Aureum Pharma AB for exclusive rights with a minimum commitment of SEK 37 million -4,61% | 0,57 MDKK

2022-05-10 10:00:00 DanCann Pharma A/S appoints Martin Vedel Ernst as new Chief Financial Officer -1,27% | 0,11 MDKK

2022-05-06 10:00:00 DanCann Pharma's CEO: Building organization and strong results from the acquisition of CannGros ApS +3,21% | 0,07 MDKK

2022-05-02 10:30:00 DanCann Pharma A/S strengthens the Board of Directors with experienced investment profile Tue Østergaard -7,17% | 0,17 MDKK

2022-04-27 15:00:00 DanCann Pharma A/S: Minutes of annual general meeting -4,62% | 0,15 MDKK

2022-04-13 14:00:00 Correction: DanCann Pharma A/S publishes Annual Report 2021 -1,45% | 0,54 MDKK

2022-04-13 08:00:00 DanCann Pharma A/S nominates Tue Østergaard to the Board of Directors at the Company's Annual General Meeting -1,45% | 0,54 MDKK

2022-04-12 22:30:00 Correction: DanCann Pharma A/S Announces the appointment of Louise Conradsen to accelerate growth as new subsidiary CEO of CannGros ApS -1,45% | 0,54 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2022-11-04	Kvartalsrapport 2022-Q3
2022-09-20	Extra Bolagsstämma 2022
2022-08-31	Kvartalsrapport 2022-Q2
2022-05-18	Kvartalsrapport 2022-Q1
2022-04-27	Årsstämma 2022
2022-04-08	Ordinarie utdelning DANCAN 0.00 DKK
2022-02-25	Bokslutskommuniké 2021
2021-11-26	Kvartalsrapport 2021-Q3
2021-08-27	Kvartalsrapport 2021-Q2
2021-07-23	Extra Bolagsstämma 2021
2021-05-28	Kvartalsrapport 2021-Q1
2021-04-29	Ordinarie utdelning DANCAN 0.00 DKK
2021-04-28	Årsstämma 2021
2021-02-26	Bokslutskommuniké 2020

DanCann Pharma

Kalender

Beskrivning

DanCann Pharma

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden